Valuation Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:52 2026-07-13 am EDT			5-day change	1st Jan Change
2,616.90 ^INR	+1.22%		-0.31%	+42.13%

May. 14	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
May. 14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	198,915	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	30.68%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	198,915	198,915	198,915
Change	-	68.55%	-12.11%	120.88%	52.16%	30.68%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	27.6x	24.2x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.46x	4.06x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.8x	1.7x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.99x	7.09x
EV / Revenue	0x	0x	0x	0x	0x	9.35x	7.99x	7.09x
EV / EBITDA	0x	0x	0x	0x	0x	26.8x	23.1x	20.3x
EV / EBIT	0x	0x	0x	-	0x	25.6x	21.3x	18.5x
EV / FCF	0x	0x	0x	0x	0x	52.4x	36.2x	36.8x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.77%	2.72%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.15%	0.15%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,585.40	2,585.40	2,585.40
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	5/6/21	5/12/22	5/27/23	5/16/24	5/15/25	5/14/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	31.88x	-	-	-	2.06B
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.34x	6.68x	23.09x	0.82%	48.69B
OTSUKA HOLDINGS CO., LTD.	18.59x	2.09x	9.88x	1.3%	36.38B
CIPLA LIMITED	27.68x	3.42x	17.52x	0.85%	12.19B
ZYDUS LIFESCIENCES LIMITED	27.28x	4.02x	16.36x	0.58%	12.04B
KRKA, D. D.	19.11x	3.34x	11.99x	3.48%	9.04B
GEDEON RICHTER	8.44x	1.99x	5.2x	5.13%	7.09B
ONO PHARMACEUTICAL CO., LTD.	16.21x	2.08x	7.01x	3.23%	7.06B
GLENMARK PHARMACEUTICALS LIMITED	34.65x	3.95x	16.81x	0.23%	6.75B
Average	24.35x	3.45x	13.48x	1.95%	15.7B
Weighted average by Cap.	26.25x	4.15x	15.82x	1.41%